Vertex Pharmaceuticals (VRTX)
NASDAQ: VRTX
· Real-Time Price · USD
392.76
2.46 (0.63%)
At close: Aug 15, 2025, 3:59 PM
392.79
0.01%
After-hours: Aug 15, 2025, 05:49 PM EDT
Vertex Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 11.42B | 11.1B | 11.02B | 10.62B | 10.33B | 10.18B | 9.87B | 9.65B | 9.51B | 9.21B | 8.93B | 8.7B | 8.35B | 7.95B | 7.57B | 7.13B | 6.68B | 6.41B |
Cost of Revenue | 1.59B | 1.55B | 1.53B | 1.48B | 1.4B | 1.34B | 1.26B | 1.18B | 1.15B | 1.1B | 1.08B | 1.04B | 991.51M | 957.68M | 904.21M | 859.91M | 809.58M | 766.13M |
Gross Profit | 9.83B | 9.55B | 9.49B | 9.15B | 8.93B | 8.84B | 8.61B | 8.48B | 8.36B | 8.11B | 7.85B | 7.66B | 7.36B | 6.99B | 6.67B | 6.27B | 5.87B | 5.65B |
Operating Income | 3.92B | -742.3M | -232.9M | -270.4M | -348.6M | 4.19B | 3.83B | 3.88B | 3.97B | 4.05B | 4.31B | 4.15B | 4.08B | 2.94B | 2.78B | 2.65B | 2.27B | 3.02B |
Interest Income | 503.7M | 537.8M | 598.1M | 649.4M | 685.1M | 673.3M | 614.7M | 521.2M | 399.5M | 265.6M | 144.6M | 59.8M | 14.72M | 5.05M | 4.91M | 6.03M | 8.02M | 11.13M |
Pretax Income | 4.37B | -300.2M | 248.5M | 259.6M | 214.7M | 4.77B | 4.38B | 4.31B | 4.31B | 4.17B | 4.23B | 4.03B | 3.93B | 2.86B | 2.73B | 2.75B | 2.41B | 3.28B |
Net Income | 3.64B | -988.9M | -535.6M | -479.8M | -489.9M | 4.02B | 3.62B | 3.47B | 3.36B | 3.26B | 3.32B | 3.27B | 3.19B | 2.45B | 2.34B | 2.18B | 1.99B | 2.76B |
Selling & General & Admin | 1.57B | 1.52B | 1.46B | 1.46B | 1.35B | 1.24B | 1.14B | 1.03B | 1.02B | 970.6M | 944.7M | 932.5M | 883.89M | 863.19M | 840.07M | 796.71M | 783.07M | 780.27M |
Research & Development | 3.83B | 8.27B | 8.16B | 8.51B | 8.49B | 3.98B | 3.85B | 3.19B | 2.98B | 2.68B | 2.54B | 2.54B | 2.39B | 3.2B | 3.05B | 2.82B | 2.82B | 1.84B |
Other Expenses | 505.7M | 503.1M | 102M | -543.9M | -559.2M | -558.1M | -212.8M | 371.2M | 397.6M | 408.7M | 56M | 31.6M | 5.2M | -5.9M | 1.6M | 1.6M | 1.6M | 9.2M |
Operating Expenses | 5.91B | 10.29B | 9.72B | 9.42B | 9.28B | 4.65B | 4.77B | 4.6B | 4.39B | 4.06B | 3.54B | 3.51B | 3.28B | 4.06B | 3.89B | 3.62B | 3.61B | 2.63B |
Interest Expense | 17M | 23.2M | 30.6M | 38.4M | 41.8M | 43.1M | 44.1M | 45.1M | 47.9M | 51.3M | 54.8M | 58.3M | 59.85M | 60.73M | 61.51M | 62.7M | 61.3M | 59.69M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.5B | 11.84B | 11.25B | 10.9B | 10.69B | 5.99B | 6.04B | 5.78B | 5.54B | 5.16B | 4.62B | 4.55B | 4.27B | 5.01B | 4.8B | 4.48B | 4.42B | 3.39B |
Income Tax Expense | 736.4M | 688.7M | 784.1M | 739.4M | 704.6M | 748M | 760.2M | 839.3M | 941.3M | 909.4M | 910.4M | 753.3M | 738.21M | 413.13M | 388.26M | 571.89M | 419.51M | 518.19M |
Shares Outstanding (Basic) | 256.7M | 256.9M | 257.5M | 258M | 258.1M | 258.2M | 257.7M | 258M | 257.7M | 257.4M | 256.9M | 256.5M | 255.9M | 255.1M | 254.6M | 257.88M | 258.99M | 259.37M |
Shares Outstanding (Diluted) | 258.9M | 259.5M | 260.5M | 261M | 258.1M | 261.1M | 260.9M | 260.6M | 260.4M | 260.3M | 260.3M | 259.5M | 258.7M | 257.9M | 257M | 259.71M | 261.02M | 261.92M |
EPS (Basic) | 14.14 | -3.8 | -2.06 | -1.85 | -1.89 | 15.58 | 14.04 | 13.47 | 13.09 | 12.71 | 12.98 | 12.81 | 12.48 | 9.57 | 9.10 | 8.40 | 7.66 | 10.62 |
EPS (Diluted) | 13.99 | -3.92 | -2.2 | -1.99 | -2.03 | 15.41 | 13.89 | 13.33 | 12.95 | 12.56 | 12.83 | 12.68 | 12.37 | 9.50 | 9.03 | 8.33 | 7.58 | 10.50 |
EBITDA | 4.67B | -76.3M | 484.9M | 517.7M | 465.1M | 5.01B | 4.61B | 4.51B | 4.51B | 4.37B | 4.44B | 4.23B | 4.13B | 3.06B | 2.92B | 2.93B | 2.59B | 3.45B |
EBIT | 4.39B | -277M | 279.1M | 298M | 256.5M | 4.81B | 4.42B | 4.35B | 4.35B | 4.22B | 4.29B | 4.08B | 3.99B | 2.93B | 2.79B | 2.81B | 2.47B | 3.34B |
Depreciation & Amortization | 283.7M | 202.1M | 207.2M | 219.7M | 208.6M | 196M | 181.3M | 160.7M | 155.3M | 151.2M | 148.3M | 143.73M | 138.73M | 132.73M | 125.66M | 121.19M | 116.13M | 111.53M |